Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 61076 - 61100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Protoporphyrin	Experimental	FOS	2353	upregulated	protoporphyrin IX results in increased expression of FOS mRNA	14q24.3	A22867
Protoporphyrin	Experimental	MMP2	4313	downregulated	protoporphyrin IX results in decreased expression of MMP2 mRNA	16q12.2	A23723
Protoporphyrin	Experimental	SLC2A1	6513	downregulated	protoporphyrin IX results in decreased expression of SLC2A1 mRNA	1p34.2	A23723
Puerarin	Investigational	ACLY	47	upregulated	puerarin results in increased expression of ACLY mRNA	17q21.2	A21627
Puerarin	Investigational	AQP1	358	upregulated	puerarin results in increased expression of AQP1 mRNA	7p14.3	A21627
Puerarin	Investigational	AQP3	360	upregulated	puerarin results in increased expression of AQP3 mRNA	9p13.3	A21627
Puerarin	Investigational	AR	367	downregulated	puerarin results in decreased expression of AR mRNA	Xq12	A21627
Puerarin	Investigational	BCL2	596	downregulated	puerarin results in decreased expression of BCL2 mRNA	18q21.33	A23724
Puerarin	Investigational	BIRC5	332	downregulated	puerarin results in decreased expression of BIRC5 mRNA	17q25.3	A23724
Puerarin	Investigational	CDH1	999	upregulated	puerarin results in increased expression of CDH1 mRNA	16q22.1	A21627
Puerarin	Investigational	CYGB	114757	downregulated	puerarin results in decreased expression of CYGB mRNA	17q25.1	A21627
Puerarin	Investigational	DSG3	1830	downregulated	puerarin results in decreased expression of DSG3 mRNA	18q12.1	A21627
Puerarin	Investigational	EGF	1950	downregulated	puerarin results in decreased expression of EGF mRNA	4q25	A21627
Puerarin	Investigational	ESR2	2100	downregulated	puerarin results in decreased expression of ESR2 mRNA	14q23.2-q23.3	A21627
Puerarin	Investigational	FBN1	2200	downregulated	puerarin results in decreased expression of FBN1 mRNA	15q21.1	A21627
Puerarin	Investigational	FBN2	2201	downregulated	puerarin results in decreased expression of FBN2 mRNA	5q23.3	A21627
Puerarin	Investigational	FGF1	2246	upregulated	puerarin results in increased expression of FGF1 mRNA	5q31.3	A21627
Puerarin	Investigational	FOS	2353	upregulated	puerarin results in increased expression of FOS mRNA	14q24.3	A21285
Puerarin	Investigational	HAS1	3036	downregulated	puerarin results in decreased expression of HAS1 mRNA	19q13.41	A21627
Puerarin	Investigational	HSPB1	3315	upregulated	puerarin results in increased expression of HSPB1 mRNA	7q11.23	A21627
Puerarin	Investigational	IGF1	3479	downregulated	puerarin results in decreased expression of IGF1 mRNA	12q23.2	A21627
Puerarin	Investigational	IL1A	3552	downregulated	puerarin results in decreased expression of IL1A mRNA	2q14.1	A21627
Puerarin	Investigational	KL	9365	downregulated	puerarin results in decreased expression of KL mRNA	13q13.1	A21627
Puerarin	Investigational	MC1R	4157	downregulated	puerarin results in decreased expression of MC1R mRNA	16q24.3	A21627
Puerarin	Investigational	NOS2	4843	downregulated	puerarin results in decreased expression of NOS2 mRNA	17q11.2	A21627

Displaying entries 61076 - 61100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability